NAVI Q1 2026 Earnings EPS Beat Drives Positive Stock Response ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds ICFI Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady FRAF Q1 2026 Earnings EPS Beats Estimates by 828 Stock Rises INTS Q1 2026 Earnings EPS Beat Despite PreRevenue Status Shares Edge Higher Paycom Q1 2026 Earnings EPS Tops Estimates Stock Slips Despite Strong Performance